期刊文献+

原发性高血压患者尿Alb、IgG、IgA、IgM及清除率变化意义的探讨 被引量:6

Comparison of the patients with essential hypertension and normal subjects on urinary excretion rate and clearance of albumine and immunoglobulines
原文传递
导出
摘要 本文对80例正常人与120例原发性高血压患者,常规尿检验蛋白阴性或微量,用精确的定量法测定尿微量Alb及IgG、A、M浓度.发现高血压患者尿内上述蛋白排泄率均明显高于正常人,分别为P<0.001、P<0.01、P<0.01、P<0.01,其中Alb、IgG与测定时血压相关(SBP与尿Alb:P<0.01,DBP与尿Alb:P<0.05,DBP与尿IgG:P<0.05).用IgG清除率/alb清除率配对比较发现原发性高血压患者的比值明显高于正常人(P<0.001)。进一步将高血压患者按WHO标准分成三期,发现此比值进行性减低(分别为1.47±2.06,1.11±1.04,0.895±0.81;与正常人比分别为P<0.2,P<0.001,P<0.02)。上述结果可见原发性高血压患者有明显升高的尿IgG、Alb排泄率,并与血压相关,随着高血压病进一步发展,从Ⅰ期~Ⅲ期,尿白蛋白排泄率进行性增加,其增加程度比IgG更明显,提示尿Alb是高血压病引起血管损伤及肾血管早期病变的敏感指标。 In 120 untreated patients with essential hypertension and 80 normal subjects, who all had negative or trace proteinuria in routine examination, unriary excretion rates and clearances of albumin and 1gG, 1gA, 1gM were examined by ELTA. Urinary excretion rates of albumin (A1b), and 1gG, A, M in essential hypertension were significantly higher than those in normal subjects (P<0.001, P<0.01, P<0.01, P<0.01, respectively). There were positive correlations between urinary A1b excretion rate and systolic blood pressure (P<0.01), diastolic blood pressure (P<0.01) and between urinary 1gG excretion rate and systolic blood pressure (P<0.05) in hypertensive group. As to the 1gG clearance/A1b clearance ratio, significant differences were shown between hypertensives and normal subjects (1.14±1.26, 2.84±3.71, respectively, P<0.001). Furthermore, 1gG clearance/A1b clearance ratio were decreased step by step in Ⅰ,Ⅱ, Ⅲ stages divided according to WHO criteria (1.47±2.06,1.11±1.04, 0.89±0.81, in comparison with the control, P<0.2, P<0.001, P<0.02, respectively). ln conclusion, the change of urinary A1b may be an early sensitive indicator of the vascular consequence of high blood pressure and as a maker, urinary A1b excretion rate seems to be much better than 1gG.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 1992年第2期66-69,共4页 Journal of Clinical Cardiology
  • 相关文献

同被引文献14

  • 1郑佐娅,陶义训.微量白蛋白尿的检测及临床意义[J].上海医学检验杂志,1994,9(4):231-232. 被引量:19
  • 2侯凡凡,武建国.肾脏病患者的微量蛋白尿[J].中华肾脏病杂志,1989,5(2):76-79. 被引量:5
  • 3梁琳琅,刘国良.糖尿病性蛋白尿电荷选择性的研究[J].中华内分泌代谢杂志,1996,12(3):138-140. 被引量:35
  • 4邹文泉 张本立 等.血尿α1-微球蛋白测定在肾脏病中的意义[J].中华肾脏病学杂志,1992,8:27-27.
  • 5吉田和清.α微球蛋白在临床检验中的应用[J].国外医学临床生物化学和检验学分册,1990,11:35-36.
  • 6方国祥,实用内科杂志,1986年,64卷,12期,656页
  • 7郭翼珍,临床心血管病杂志,1992年,8卷,2期,5页
  • 8陈仁涉.微量白蛋白发生机制、预后及治疗[J].国外医学临床微生物与检验分册,2000,18(2):156-158.
  • 9Chalmers J, MacMahon S, Mancia G, et al. 1999 world health organization-International society of hypertension guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization[J].Clin Exp Hypertens, 1999,21(5-6):1009-1060.
  • 10谢服役,史受兰.肾病患者尿α1—MG,β2—MG RIA联合检测的临床意义[J].中国实验临床免疫学杂志,1997,9(3):37-39. 被引量:5

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部